From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

SHOCKING Julie Meyer email - was she committing fraud as she tried to raise money for Ariadne

By Tom Winnifrith | Saturday 12 May 2018


 


 Oh dear. Oh dear. Losing her Maltese regulatory license yesterday was bad enough for Julie Meyer MBE. Having the HMRC open an investigation on Thursday was also bad. And having Maltese magistrates blast her on Wednesday about her fleeing criminal charges was really bad. Now it gets worse as an email from the devout Christian has emerged (see below) which begs the question as to whether Julie Meyer attempted to defraud investors in 2017. Did she commit fraud? Judge for yourself...

We know that as late as November 26 2017 Meyer was tring to raise cash for Ariadne Capital Limited even though she was already talking to the administrators who were appointed two weeks later and even though we - know know - that Ariadne had no cash or assets at that point. Thanks to Winnileaks, we demonstrated that point HERE earlier in the week.

Thanks to Winnileaks (see HERE) we also know that on 6 October she was telling a potential investor in Ariadne how well it was doing. Praise the Lord wrote:

Ariadne Capital Limited (London) performed well, and this is the reason it’s Net Assets are £4 m. Up until 2016, EntrepreneurCountry was a part of ACL, but with the acquisition of Malta, and the need to keep regulated and unregulated businesses separate, we separated EC out. However, due to the years of investment that ACL has made in EC, there is a 33% of EC revenue in perpetuity stream back to ACL that ACL enjoys. So if you look at the EC and ACL combination that would be closer to the natural progression of ACL 2015 and 2016 revenue for 2017. Amit is doing a great job managing both.

The €7.5 m founding shareholder round is as follows:

The £4 m or €4.8 m of founding shareholders in ACL through a Net Asset uplift or acquisition are part of the €7.5 m founding shareholder round. In addition, we have €1.5 m in the bank fully subscribed. And in the last €1.2 m to make up the €7.5 m, we have strong interest from great investors to get us across the line. That round technically closed last Friday, so I’m eager to answer any questions you have. No investor has mentioned that they are concerned about me getting to the full amount. I’m not concerned at all about this either.

Ends.

Well that was a pack of lies wasn't it?

And here is further proof of that. An email dated 28 February 2017 which reveals the true state of Ariadne. I quote "Ariadne London has been in decline for three years, each year its revenues have fallen. The business is bleeding cash and has lost £45k in Jan 2017 again causing us to pay salaries late etc. Anybody rational or anyone without a reputation would have shut down the firm"

Now I remind you what the Fraud Act of 2006 states:

Fraud Act 2006: (i) to make a gain for himself or another, or (ii) to cause loss to another or to expose another to a risk of loss. (2) A representation is false if— (a) it is untrue or misleading, and (b) the person making it knows that it is, or might be, untrue or misleading

Now in light of the email below I question whether the attempts by Meyer to raise cash for Ariadne Capital Limited throughout 2017 but especially in October and November constitute fraud? What do you think. 

 

Click to enlarge

This story is available to all readers
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:


Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:54:53